Characterization of the mTOR pathway in human normal adrenal and adrenocortical tumors
Maria Cristina De Martino(Istituto Nazionale di Fisica Nucleare, Sezione di Napoli), Leo J. Hofland(Erasmus MC)
Cited by 25
Related Papers
Complications of Cushing's syndrome: state of the art
|The Lancet Diabetes & Endocrinology|2016|602
The Pathophysiological Consequences of Somatostatin Receptor Internalization and Resistance
|Endocrine Reviews|2003|475
Cardiovascular Risk Factors and Common Carotid Artery Caliber and Stiffness in Patients with Cushing’s Disease during Active Disease and 1 Year after Disease Remission
|The Journal of Clinical Endocrinology & Metabolism|2003|355
The Medical Treatment of Cushing’s Disease: Effectiveness of Chronic Treatment with the Dopamine Agonist Cabergoline in Patients Unsuccessfully Treated by Surgery
|The Journal of Clinical Endocrinology & Metabolism|2008|326
Telomerase reverse transcriptase promoter mutations in tumors originating from the adrenal gland and extra-adrenal paraganglia
|Endocrine Related Cancer|2014|43